Periodic Reporting for period 1 - EscaPI (Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma)

Resistance to anticancer drugs, which often develops from a heterogeneous pool of drug-tolerant cells known as minimal residual disease (MRD), is thought to mainly occur through acquisition of genetic alterations. Emerging evidence indicates that drug resistance may also be...